Echo Therapeutics (ECTE +1.9%) says that its priced its full 4.628M share public offering, which...

|About: Echo Therapeutics (ECTE)|By:, SA News Editor

Echo Therapeutics (ECTE +1.9%) says that its priced its full 4.628M share public offering, which includes the full over-allotment exercise, at $2.70 per share, an actual 3% premium to today's closing price of $2.62. Demand for the deal was high, and the sale will generate around $12.5M in gross proceeds before the underwriting discount and other offering costs are deducted. Shares +1.9% AH.